SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-21-000065
Filing Date
2021-11-05
Accepted
2021-11-05 09:05:58
Documents
3
Period of Report
2021-11-05

Document Format Files

Seq Description Document Type Size
1 6-K form6kq3results.htm 6-K 18300
2 EX-99.1 oncyq32021pr.htm EX-99.1 218861
3 image_0.jpg GRAPHIC 933863
  Complete submission text file 0001129928-21-000065.txt   1524522
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 211382610
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences